Biotech

All Articles

Metsera join Amneal to secure down GLP-1 source

.Along with early phase 1 information right now out in the wild, metabolic illness attire Metsera is...

Rivus articles data to support muscle-sparing being overweight drug insurance claims

.Rivus Pharmaceuticals has introduced the data responsible for its phase 2 obesity succeed in heart ...

BMS pays $110M to develop T-cell treatment treaty, assisting Main buy time to improve prioritized pipeline

.Bristol Myers Squibb is actually paying for Top Medication $110 thousand ahead of time to cultivate...

Generate increases an additional $1B-plus Large Pharma alliance

.Novartis has printer inked an offer possibly worth greater than $1 billion with Flagship-founded Ge...

Metsera GLP-1 information piece uncovers 7.5% fat burning at 36 times

.Lately debuted Metsera is unfolding some stage 1 record for its GLP-1 receptor agonist, exposing a ...

Flagship hopes biotechs group to Mirai to enhance genetic meds

.Surrounded by the genetic medicines arms ethnicity, Flagship Pioneering is revealing a new firm to ...

BioAge eyes $180M from IPO, exclusive positioning for obesity trials

.BioAge Labs is actually eyeing all around $180 thousand in first profits from an IPO and an exclusi...

Merck's LAG-3 combination stops working intestines cancer cells period 3 study

.An attempt by Merck &amp Co. to unlock the microsatellite secure (MSS) metastatic intestines cancer...

Spanish VC finalizes $200M life sciences fund

.Spain-based Asabys Allies has actually shut a fund of 180 thousand euros ($ 200 million), amount of...

BioAge introduces $198M coming from IPO as weight problems biotech joins Nasdaq

.BioAge Labs is introducing virtually $200 thousand through its Nasdaq IPO today, with the earnings ...